Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?

Jixiang ZhangShimin LuXiaoli WangXuemei JiaJiao LiHongbo LeiZhengru LiuFei LiaoMengyao JiXiaoguang LvJian KangShan TianJingjing MaDandan WuYang GongYu XuWeiguo Dong

Published in: Heart (British Cardiac Society) (2020)

Considering the high prevalence of CVD, a thorough CVD assessment at diagnosis and early intervention are recommended in COVID-19 patients with CVD. Patients with CVD are more vulnerable to deterioration.

Keyphrases

cardiovascular disease
coronavirus disease
sars cov
randomized controlled trial
type diabetes
respiratory syndrome coronavirus